SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

NCT00936520 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Preliminary analysis showed little or no bioactivity.

Conditions

Diabetic Macular Edema (DME)
Pars Plana Vitrectomy

Interventions

DRUG: SAR 1118 0.1%
DRUG: SAR 1118 1.0%
DRUG: SAR 1118 5.0%

Sponsor

Johns Hopkins University

Collaborators

[object Object]